Which immunization for children treated for solid tumors?;Vaccination de l'enfant traité pour tumeur solide: Quelle conduite à tenir?

Archives de Pediatrie

Volumn 8, Issue 7, 2001, Pages 734-743

  Marec Berard P ^a   Floret, D ^b   Schell, M ^a   Mialou, V ^a   Frappaz, D ^a   Philip, T ^a   Bergeron, C ^a  

^a CENTRE LÉON BÉRARD   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Child; Drug therapy; Immunization; Neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MEASLES VACCINE; MUMPS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE; TETANUS TOXOID; YELLOW FEVER VACCINE;

ANTIBODY TITER; ASPLENIA; CANCER CHEMOTHERAPY; CHILD; DRUG INDICATION; DRUG MEGADOSE; HUMAN; IMMUNIZATION; INFECTION PREVENTION; LYMPHOCYTE COUNT; PRACTICE GUIDELINE; REVACCINATION; REVIEW; SEROLOGY; SOLID TUMOR; VACCINATION;

EID: 0346308837     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(00)00308-0     Document Type: Short Survey

References (64)

1. La vaccination des enfants immunodéprimés
2. Active immunization of children with leukemia and other malignancies
3. Lymphocyte function after autologous bone-marrow transplantation (BMT): A comparison with patients treated with allogeneic BMT and with chemotherapy only
4. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia
5. Immune recovery in children malignancy after cessation of chemotherapy
6. Studies on the immune status of children with acute lymphoblastic leukemia
7. Depression of immunologic reactivity of patients with acute leukemia
8. Immunization response varies with intensity of acute lymphoblastic leukemia therapy
9. Recovery of blood lymphocytes and serum immunoglobulins after treatment of solid tumors in children
10. Hodgkin's disease: Long term bone marrow effects of therapy
11. Immunologic rebound after cessation of long-term chemotherapy in acute leukemia
12. Immune reconstitution after chemotherapy for malignant solid tumors in children
13. Immunité humorale et infections pendant l'autogreffe de moelle osseuse chez l'enfant: Étude de 127 patients greffés successivement dans un même centre
14. Numerical changes in various peripheral white blood cells in children as a result of antineoplastic therapy
15. Antibody production following immunization with diphteria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease
16. Efficiency of tetanus toxoid booster in leukemic children
17. Immunity to diphteria, pertussis, tetanos, and poliomyelitis in children with acute lymphocytic leukemia after cessation of chemotherapy
18. Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients
19. Poliovirus antibody response in patients with acute leukemia
20. Antibody response to poliovirus immunization in childhood leukemia
21. Vaccination calendar and new risks of infection
22. Measles and rubella antibody status in previously vaccinated children with cancer
23. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia
24. Immunity to and immunization against measles, rubelle and mumps in patients after autologous bone marrow transplantation
25. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients
26. Attenuated measles vaccine in children with acute leukemia
27. Risk of Haemophilus influenza type b disease in children with cancer and response of immunocompromized leukemic children to a conjugate vaccine
28. Update: Prevention of Haemophilus influenza type b infections in the United States
29. Bacteremia due to Haemophilus influenzae and Streptococcus pneumoniae; their occurrence and course in children with cancer
30. Response of immunocompromized children with solid tumors to a conjugate vaccine for Haemophilus influenzae type b
31. Antibody response to immunization with Haemophilus influenza type b polysaccharide vaccine in children with cancer
32. Response of children with acute lymphoblastic leukemia [ALL] to H. influenza type b [Hib] conjugate vaccine
33. Immunization of leukemic children with Haemophilus conjugate vaccine
34. Whooping cough today
35. Passive and active anti-hepatitis B immunization of children with hematologic malignancies
36. Hepatitis B virus markers in children with acute leukemia: The effect of chemotherapy
37. Hepatitis B vaccination and immune response in children with malignant disease
38. Hepatitis B vaccination in children with cancer
39. Impaired response to hepatitis B vaccine in children receiving anticancer chemotherapy
40. Efficacy of immunization against hepatitis B virus infection in children with cancer
41. Acyclovir prophylaxis of varicella after household exposure
42. Protection against varicella in family contacts by immediate inoculation with varicella vaccine
43. Postexposure varicella vaccination in siblings of children with active varicella
44. Prise en charge des infections à virus varicelle zona. Conférence de consensus de la Société de pathologie infectieuse de langue française [SPILF]
45. Live attenuated varicella vaccine: Protection in healthy adults compared with leukemic children
46. Active immunization against varicella of children with acute leukemia or other malignancies on maintenance chemotherapy
47. OKA strain live varicella vaccine in children with cancer
48. Varicella for immunocompromized children: Results of collaborative studies in the United States and Canada
49. Study of tolerance and effectiveness of a varicella vaccine in leukemic children
50. Vaccination of chickenpox in children with acute lymphoblastic leukemia
51. Complications in two children with acute lymphoblastic leukemia caused by vaccination against varicella zoster virus
52. Efficacy of varicella vaccine in patients with solid tumors
53. Administration of live attenuated varicella vaccine to children with cancer before starting chemotherapy
54. Prévention de la varicelle chez l'immunodéprimé
55. Antibody response to pneumococcal vaccine in patients with solid tumors and lymphomas
56. Response of patients with Hodgkin's disease to pneumococcal vaccine
57. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease
58. Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin's disease
59. Bacteraemia in adults after splenectomy or splenic irradiation
60. Functional hyposplenia after splenic irradiation for Hodgkin's disease
61. Splenic injury caused by therapeutic irradiation
62. Dépistage des individus et des groupes à risque: Spécificité de la stratégie de dépistage, de la prise en charge, du suivi